Ginkgo Bioworks Inc. (DNA) Statistics & Valuation Metrics - Stocknear

Ginkgo Bioworks Inc.

NYSE: DNA · Real-Time Price · USD
16.14
0.17 (1.06%)
At close: Oct 03, 2025, 3:59 PM
16.07
-0.43%
After-hours: Oct 03, 2025, 07:51 PM EDT

Ginkgo Bioworks Statistics

Share Statistics

Ginkgo Bioworks has 55.43M shares outstanding. The number of shares has increased by 2.99% in one year.

55.43M
2.99%
1.14%
60.8%
47.68M
15,028
0.86%

Short Selling Information

The latest short interest is 6.27M, so 10.6% of the outstanding shares have been sold short.

6.27M
10.6%
13.67%
3.77

Valuation Ratios

The PE ratio is -0.93 and the forward PE ratio is -3.67. Ginkgo Bioworks's PEG ratio is 0.02.

-0.93
-3.67
2.24
4.4
0.71
-1.33
0.02
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Ginkgo Bioworks.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 5.62, with a Debt / Equity ratio of 0.65.

5.62
5.62
0.65
-0.97
-1.22
-5954.86

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$272.23K
$-655.91K
834
0.16
n/a

Taxes

-479K
0.09%

Stock Price Statistics

The stock price has increased by 93.76% in the last 52 weeks. The beta is 1.55, so Ginkgo Bioworks's price volatility has been higher than the market average.

1.55
93.76%
12.38
10.04
73.35
1,750,867

Income Statement

In the last 12 months, Ginkgo Bioworks had revenue of 227.04M and earned -547.03M in profits. Earnings per share was -10.54.

227.04M
188.49M
-559.76M
-547.03M
-484.39M
-547.41M
-10.54
Full Income Statement

Balance Sheet

The company has 561.57M in cash and 467.73M in debt, giving a net cash position of 93.84M.

561.57M
467.73M
93.84M
-5.84B
1.23B
426.31M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -319.58M and capital expenditures -62.54M, giving a free cash flow of -382.13M.

-319.58M
-62.54M
-382.13M
-7.36
Full Cash Flow Statement

Margins

Gross margin is 83.02%, with operating and profit margins of -246.54% and -240.94%.

83.02%
-246.54%
-241.15%
-240.94%
-213.35%
-246.54%
-168.31%

Dividends & Yields

DNA does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for DNA is $9, which is -44.2% lower than the current price. The consensus rating is "Sell".

$9
-44.2%
Sell
1
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Aug 20, 2024. It was a backward split with a ratio of 1:40.

Aug 20, 2024
backward
1:40

Scores

-6.55
4